Roger Mächler, Chief Financial Officer, Octapharma Group

Financial

The Importance of a Solid Financial Basis

 

2011 Key Figures:

  • Net sales: €732 million
    Increased by 2% compared to 2010.
  • Operating Income: €64 million
    Increased by 164% compared to 2010
  • Net profit of the year: €72 million
    Increased by 57% compared to 2010.
  • Operating costs: €141 million  
    Includes €43 million investments into R&D.
  • Investments: €48 million
    The production capacity is increasing across the production sites.
  • Equity ratio: 79%